[The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
Results are reported of the treatment of 116 patients with a control group pulmonary tuberculosis. Patients of the main group (76 persons) received thymalin at the early stages of chemotherapy. Results were compared with a control group. It is shown that immunochemotherapy allows to increase the treatment efficacy earlier with a parallel restoration of cellular immunity indices.
Ivanova
L A
LA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D008297:Male; D012397:Rosette Formation; D013951:Thymus Hormones / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000995:Antitubercular Agents; D013951:Thymus Hormones; C032805:thymalin
Primenenie timalina v kompleksnoĭ khimioterapii bol'nykh infil'trativnym destruktivnym tuberkulezom legkikh.